Factor V Leiden, factor V Cambridge, factor II GA20210, and methylenetetrahydrofolate reductase in cerebral venous and sinus thrombosis: A case-control study
| Autor: | Marzieh Tajmirriahi, Elham Asadimobarakeh, Ehsan Kheradmand, Gilda Amini, Mansour Salehi, Mehri Salari, Rasoul Salehi, Homa Ebrahimi, Mohammad Saadatnia, Seyed Ziaeddin Samsam Shariat, Ahmad Movahedian |
|---|---|
| Rok vydání: | 2015 |
| Předmět: |
Pediatrics
medicine.medical_specialty Population lcsh:Medicine Gene mutation Gastroenterology Internal medicine Factor V Leiden Cerebral venous and sinus thrombosis Medicine Sinus thrombosis factor V Cambridge education education.field_of_study biology business.industry lcsh:R Case-control study General Medicine medicine.disease Factor ii methylenetetrahydrofolate reductase Factor V Cambridge factor II GA20210 Methylenetetrahydrofolate reductase factor V Leiden biology.protein Original Article business |
| Zdroj: | Journal of Research in Medical Sciences : The Official Journal of Isfahan University of Medical Sciences Journal of Research in Medical Sciences, Vol 20, Iss 6, Pp 554-562 (2015) |
| ISSN: | 1735-1995 |
| Popis: | Background: Factor V G1691A (FV Leiden), FII GA20210, and methylenetetrahydrofolate reductase (MTHFR) C677T mutations are the most common genetic risk factors for thromboembolism in the Western countries. However, there is rare data in Iran about cerebral venous and sinus thrombosis (CVST) patients. The aim of this study was to evaluate the frequency of common genetic thrombophilic factors in CVST patients. Materials and Methods: Forty consequently CVST patients from two University Hospital in Isfahan University of Medical Sciences aged more than 15 years from January 2009 to January 2011 were recruited. In parallel, 51 healthy subjects with the same age and race from similar population selected as controls. FV Leiden, FII GA20210, MTHFR C677T, and FV Cambridge gene mutations by polymerase chain reaction technique were evaluated in case and control groups. Results: FV Leiden, FII GA20210, and FV Cambridge gene mutations had very low prevalence in both case (5%, 2%, 0%) and control (2.5%, 0%, 0%) and were not found any significant difference between groups. MTHFR C677T mutations was in 22 (55%) of patients in case group and 18 (35.5%) of control group ( P = 0.09). Conclusion: This study showed that the prevalence of FV Leiden, FII GA20210, and FV Cambridge were low. Laboratory investigations of these mutations as a routine test for all patients with CVST may not be cost benefit. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|